Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 31 Triple Negative Breast Neoplasms 19 Neoplasm Metastasis 5 Urinary Bladder Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Non-Small-Cell Lung 4 Brain Neoplasms 4 Salivary Gland Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Advanced Breast Cancer 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Bladder Carcinoma 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm, Residual 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Mouth Neoplasms 1 Meningeal Carcinomatosis 1 Lung Diseases 1 Localized Muscle Invasive Bladder Urothelial Carcinoma 1

Interventions

Carboplatin 10 Paclitaxel 5 Nivolumab 4 Pemetrexed 3 Cisplatin 3 atezolizumab 2 apatinib 2 Surveys and Questionnaires 2 One-Lung Ventilation 2 Ipilimumab 2 Blood Specimen Collection 2 Bevacizumab 2 zimberelimab 1 toripalimab 1 spartalizumab 1 sitravatinib 1 sintilimab 1 sacituzumab govitecan 1 pembrolizumab 1 lorlatinib 1 cemiplimab 1 camrelizumab 1 Vital Signs 1 Vinorelbine 1 Tyrosine Kinase Inhibitors 1 Tomography, Emission-Computed, Single-Photon 1 Temozolomide 1 Telescopes 1 Talc 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lung Diseases × sacituzumab govitecan × Clear all

NCT06431633 2026-05-18

ARIAN

Fundación GECP

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡